TheEdgeResearch
Home / Stocks / BGXX

Bright Green Corporation (BGXX)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.04 ▲ +5328.57%
Market Cap
$7.3M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.25
52-Wk Range
0.03-0.05
CEO
Lynn Stockwell
Country
US
Currency
USD

Bright Green Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Fort Lauderdale, FL, US. The stock last traded at $0.04, up 5328.57% on the session, giving a market capitalisation of $7.3M. On trailing twelve-month figures it carries a trailing P/E of -0.52, a net margin of -3269.7%. Its beta of -0.25 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.52
Price / Sales
18.09
Price / Book
0.62
EV / EBITDA
-1.10
Gross margin
-59.0%
Operating margin
-2214.6%
Net margin
-3269.7%
Return on equity
Debt / equity
0.17
Current ratio
0.04
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2022-05-17
Headquarters
Fort Lauderdale, FL, US
About Bright Green Corporation

Bright Green Corporation specializes in the cultivation, manufacturing, and distribution of cannabis and related goods. The company operates entirely within the legal frameworks of federal and state laws, providing its products for scientific inquiry, medicinal pharmaceutical purposes, and international export. Founded in 2019, its primary location is Fort Lauderdale, Florida.

Comparable companies

Bright Green Corporation is most often compared with the following Healthcare names:

AYRWFAYURFCLCFFCNFHFCRRTFIMTHLOBEFOILFFPCLOFUNVC
More research on BGXX
BGXX technical analysis BGXX TheEdge Score Compare against peers
Open full interactive analysis & DCF →